Medicare Enrolled

Dr. Steven Brooks, DO, FAOCD, MS

Procedural Dermatology Physician · Manhasset, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
444 COMMUNITY DR, Manhasset, NY 11030
5164394707
In practice since 2011 (15 years)
NPI: 1073800165 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brooks from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brooks? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brooks

Dr. Steven Brooks is a procedural dermatology physician in Manhasset, NY, with 15 years of NPI registration. Based on federal Medicare data, Dr. Brooks performed 1,368 Medicare services across 668 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brooks received a total of $32,515 from 48 pharmaceutical and/or device companies across 971 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brooks is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ 1,368 Medicare services $32,515 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,368
Medicare services
Bottom 42% in NY for procedural dermatology physician
668
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~91 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
408 $6 $14
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
339 $80 $173
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
136 $48 $163
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
134 $101 $269
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
130 $109 $251
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
99 $85 $257
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
89 $82 $242
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
17 $41 $135
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
16 $47 $130
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$32,515
Total received (2018-2024)
Avg $4,645/year across 7 years
Top 15% in NY for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
971
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,309 (56.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,318 (25.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,888 (18.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,685
2023
$2,770
2022
$3,990
2021
$3,662
2020
$2,189
2019
$3,085
2018
$10,136

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dermavant Sciences, Inc.
$3,666
Arcutis Biotherapeutics, Inc.
$435
Amgen Inc.
$431
Janssen Biotech, Inc.
$315
SUN PHARMACEUTICAL INDUSTRIES INC.
$268
LEO Pharma Inc.
$227
ABBVIE INC.
$209
Lilly USA, LLC
$173
E.R. Squibb & Sons, L.L.C.
$150
PFIZER INC.
$144
Novartis Pharmaceuticals Corporation
$138
Regeneron Healthcare Solutions, Inc.
$118
UCB, Inc.
$96
Incyte Corporation
$80
Verrica Pharmaceuticals Inc.
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Galderma Laboratories, L.P.
$35
GENZYME CORPORATION
$28
Almirall LLC
$23
Ortho Dermatologics, a division of Bausch Health US, LLC
$22
Journey Medical Corporation
$17
Top 3 companies account for 67.8% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$7,530
Dermavant Sciences, Inc.
$4,086
Medimetriks Pharmaceuticals, Inc.
$2,391
Janssen Biotech, Inc.
$1,528
Teladoc Health, Inc.
$1,425
Galderma Laboratories, L.P.
$1,346
Regeneron Healthcare Solutions, Inc.
$1,134
Encore Dermatology Inc.
$1,041
Amgen Inc.
$1,027
Novartis Pharmaceuticals Corporation
$1,023
LEO Pharma Inc.
$876
AbbVie Inc.
$869
Lilly USA, LLC
$862
Sun Pharmaceutical Industries Inc.
$856
Ortho Dermatologics, a division of Bausch Health US, LLC
$520
Arcutis Biotherapeutics, Inc.
$470
VYNE Pharmaceuticals Inc.
$445
ABBVIE INC.
$430
Mayne Pharma Inc.
$421
E.R. Squibb & Sons, L.L.C.
$417
Incyte Corporation
$403
SUN PHARMACEUTICAL INDUSTRIES INC.
$383
Celgene Corporation
$274
Promius Pharma LLC
$240
Journey Medical Corporation
$238
Taro Pharmaceuticals USA, Inc.
$238
Genentech USA, Inc.
$224
AbbVie, Inc.
$207
UCB, Inc.
$196
Merz North America, Inc.
$185
Almirall LLC
$177
GENZYME CORPORATION
$174
MAYNE PHARMA INC.
$170
DERMIRA, INC.
$160
EPI Health, LLC
$138
MAYNE PHARMA COMMERCIAL LLC
$67
Verrica Pharmaceuticals Inc.
$64
Mylan Pharmaceuticals Inc.
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
MERZ NORTH AMERICA, INC.
$30
Allergan Inc.
$24
Biofrontera Inc.
$22
Sandoz Inc.
$21
Krystal Biotech Inc
$19
Melinta Therapeutics, Inc.
$18
Sebela Pharmaceuticals Inc.
$18
TARO PHARMACEUTICALS USA, INC.
$14
Allergan, Inc.
$13
Top 3 companies account for 43.1% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMZEEQ · APEXICON E · ARAZLO · ASCLERA · Absorica LD · Aczone · Ameluz · BOTOX · BOTOX COSMETIC · BRYHALI · Baxdela · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Ceracade · Cimzia · Clindacin ETZ · Clindacin Pac · Clindamycin Phosphate and Benzoyl Peroxide · Clodan · Cloderm Cream · Cordran Tape · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EFUDEX · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · Exelderm · FINACEA · Genadur · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · Klisyri · LEVULAN KERASTICK · NAFTIN · Neo-Synalar · Neo-Synalar Cream Kit · OLUMIANT · OPZELURA · ORACEA · Olux · Otezla · PICATO · QBREXZA · REMICADE · RETIN-A MICRO · RETIN-A-MICRO · RINVOQ · SILIQ · SKYRIZI · SOLODYN · SOOLANTRA · SPEVIGO · Sernivo · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TRIANEX 0.05% · TRILUMA · TWYNEO · TargaDox · Tremfya · Trianex · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · VYJUVEK · Veltin · Winlevi · XEOMIN · Xeomin · YCANTH · ZILXI · Zelboraf · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a procedural dermatology physician in Manhasset?
Compare procedural dermatology physicians in the Manhasset area by procedure volume, costs, and industry payment transparency.
Browse procedural dermatology physicians nearby

Geographic Context

Procedural dermatology physicians within 10 mi
70
Per 100K population
5.0
County median income
$143,408
Nearest hospital
NORTH SHORE UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Brooks is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 15% of NY peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Brooks experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Brooks performed 408 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brooks receive payments from pharmaceutical companies?
Yes. Dr. Brooks received a total of $32,515 from 48 companies across 971 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brooks's costs compare to other procedural dermatology physicians in Manhasset?
Dr. Brooks's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brooks) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →